Medication info
GliphoMin M Tablet 1/250 mg

GliphoMin M Tablet 1/250 mg

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›250mg / 1 tabletGlimepiride›1mg / 1 tablet
Manufacturer / importer
Yuhan Corporation Co., Ltd.
Appearance
White oblong film-coated tablet
Packaging
30 tablets (10 tablets/PTP x 3)
Approval status
Active

MFDS item code 201107226 · Approved 2011.09.27 · Insurance code 642104120

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Administer this medicine 1 to 2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, which may be adjusted taking into account the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and it was gradually increased based on blood glucose monitoring results, with doses up to glimepiride/metformin hydrochloride 8mg/2000mg having been administered. Glimepiride as a single agent generally provides little additional benefit at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage regimen of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than a single dose at the next scheduled administration.

Ingredients

Manufacturer
Yuhan Corporation Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication helps improve blood sugar control in patients with type 2 diabetes by using glimepiride and metformin together. It is given to patients who follow meal therapy and exercise therapy and is effective in managing blood sugar levels. Therefore, it is used to enhance blood sugar control in patients with type 2 diabetes.

How to take

Adult dose

Administer this medicine 1 to 2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, which may be adjusted taking into account the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and it was gradually increased based on blood glucose monitoring results, with doses up to glimepiride/metformin hydrochloride 8mg/2000mg having been administered. Glimepiride as a single agent generally provides little additional benefit at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage regimen of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than a single dose at the next scheduled administration.

Precautions

This medication can cause severe lactic acidosis or hypoglycemia, so caution is necessary. Especially if kidney function decreases rapidly, the medication can accumulate in the body, raising the risk of lactic acidosis. If dehydration symptoms are present, it is advisable to temporarily halt the use of this medication and consult a physician. Extra caution is needed when taken with other medications that may worsen kidney function. Excessive alcohol intake, liver dysfunction, and poorly controlled diabetes can also increase the risk of lactic acidosis. This medication is not to be given to patients with insulin-dependent diabetes, acute metabolic acidosis, or severe liver or kidney dysfunction. It is also recommended that pregnant or breastfeeding women avoid using this medication. In elderly patients or those with diminished kidney function, dosage adjustment and regular monitoring of kidney function are necessary. Patients who are starting the medication or who are at a higher risk for hypoglycemia should be closely monitored for hypoglycemic symptoms. Hypoglycemic symptoms may include headaches, fatigue, trembling, and confusion, which in severe cases can lead to loss of consciousness. Gastrointestinal disturbances (nausea, diarrhea, etc.) may occur but usually resolve over time. It is important to regularly monitor blood sugar levels, kidney function, and vitamin B12 levels during the use of this medication. There may be interactions with other medications, so it is essential to inform your physician or pharmacist of any ongoing medications. Caution is particularly warranted when used with medications that may affect kidney function or enhance or reduce blood sugar-lowering effects. When driving or operating machinery, be careful of the risks of hypoglycemia or impaired agility. In case of overdose, hypoglycemia or lactic acidosis may occur, necessitating immediate consultation with healthcare professionals for appropriate treatment. This medication should be avoided in children and pregnant women, as its safety has not been established. During the use of this medication, regular meals, exercise, and blood sugar management are necessary, and immediate consultation with a physician is advised if symptoms or adverse reactions occur.

Side effects

Lactic acidosis, hypoglycemia, diarrhea, nausea, vomiting, abdominal distension, loss of appetite, indigestion, constipation, abdominal pain, metallic taste, visual impairment, taste disturbance, erythema, pruritus, urticaria, thrombocytopenia, leukopenia, hemolytic anemia, anemia, agranulocytosis, pancytopenia, peripheral neuropathy, vitamin B12 deficiency, increased liver enzymes, liver damage, bile secretion disorder, jaundice, hepatitis, allergic vasculitis, photosensitivity, decreased serum sodium concentration, decreased thyroid-stimulating hormone levels, magnesium deficiency, encephalopathy, hair loss, weight gain, abdominal pain, abdominal distension, vomiting, indigestion, palpitations, dizziness, diarrhea, nausea, leg edema, cardiac arrest, rectal carcinoma, hypoglycemia, vertigo, liver dysfunction, arthralgia, facial edema, erectile dysfunction, facial flushing, gastritis, headache, severe hunger, fatigue, sleep, weakness, drowsiness, sleep disturbances, instability, aggression, attention deficit, inability to concentrate, abnormal response, depression, confusion, speech disorder, aphasia, visual disturbance, tremor, paralysis, sensory disturbance, inability to self-regulate, delirium, cerebral seizure, loss of consciousness, coma, weak respiration, slow pulse, sweating, clammy skin, anxiety, rapid pulse, hypertension, palpitations, angina pectoris, deep vein thrombosis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air ingress, and the storage temperature should be maintained at room temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain the medication's efficacy for a longer period.

Appearance and packaging

Appearance

White oblong film-coated tablet

Package unit

30 tablets (10 tablets/PTP x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.